• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Clinical Trial Registry Accuracy and Maintenance in ALS/MND Research
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition, Swallowing and Saliva
      • Activities of Daily Living and Occupational Therapy
      • Muscles, Mobility and Exercise
      • Respiratory Care
      • Speech and Communication
      • Voice Preservation
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • Masitinib
      • NurOwn
      • CNM-Au8
      • ILB
      • AstroRx
      • Neuronata-R / Lenzumestrocel
      • PrimeC
      • NP001
      • Pridopidine
      • SOD1 Therapies and Trials
      • C9orf72 Therapies and Trials
      • SPG302
      • Regulatory T Cell Enhancing Therapies
      • Ulefnersen
    • Approved Drugs
      • Nuedexta
      • Radicava / Edaravone
      • Riluzole / Tiglutik
      • Rozebalamin / Methylcobalamin
      • Tofersen / Qalsody
    • Drugs No Longer in Development
      • AMX0035
      • Reldesemtiv
      • Arimoclomol
      • TUDCA
      • CuATSM
  • Support for Health Professionals
    • Breaking the News in ALS/MND
    • R.A.C.E. to Diagnose ALS/MND
  • Programs & Events
    • Calendar of Events
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
  • Members
    • Member Registration
    • Forgot Password

ALS/MND Health Literacy Map

A Framework for Health Literacy and Increasing Quality of Life

The ALS/MND Health Literacy Map is a framework designed to support people living with ALS/MND (PALS) and their communities (CALS) in understanding the disease, navigating care, and improving quality of life.

It covers the many topics that individuals and their loved ones need to know when faced with an ALS/MND diagnosis. At the heart of this initiative are people living with ALS/MND and their communities, whose lived experience provides a unique and essential perspective.

Preview of the ALS/MND Health Literacy Map. The full framework includes topics like understanding the disease, living with it, treatment, and advocacy.

Download the Health Literacy Map (PDF)

Explore the Health Literacy Map

The map brings together a wide range of interconnected topics across four key areas:

Understanding ALS/MND

Living with ALS/MND

Treating ALS/MND

Taking Action

Why Health Literacy Matters

Health literacy means having the ability to obtain, understand, and use health information and services to make informed decisions about one’s health and well-being. For PALS and CALS, this knowledge supports participation in care decisions and advocacy for their needs.

How the Alliance will use the map

The Health Literacy Map will help the Alliance:

  • Identify gaps and opportunities to guide future educational initiatives
  • Inform updates to our website, programs, and resources
  • Ensure information is accessible, inclusive, and available globally
  • Encourage collaboration and avoid duplication of effort across our community

Our Guiding Values

The framework is shaped by four key values that guide how we interpret and share information:

Human-centric

Inclusive, empathetic, and person-first

Global

Universally relevant, regardless of geography

Transparent

Open, collaborative, and community-informed

Accessible

Easy to consume, in multiple formats and languages

We hope this resource supports not just individuals and families, but also our wider ecosystem of healthcare professionals, researchers, industry partners, and Alliance members.

Acknowledgements

This project was developed by the ALS/MND Health Literacy Task Force and supported by a generous group of sponsors and expert contributors. We thank everyone who helped bring this framework to life.

Primary Sidebar

  • Fabrice Kamp, Germany

    Fabrice Kamp, Germany

  • Imelda Arenas, Colombia

    Imelda Arenas, Colombia

  • Leon Ryba, Argentina

    Leon Ryba, Argentina

  • Shay Rishoni, Israel

    Shay Rishoni, Israel

  • John Sweeney, USA

    John Sweeney, USA

  • Jose Rivero Muñoz, Mexico

    Jose Rivero Muñoz, Mexico

  • Jose Espinosa, Argentina

    Jose Espinosa, Argentina

  • Sam Hayden-Harler, UK

    Sam Hayden-Harler, UK

  • Liz Ogg, Scotland

    Liz Ogg, Scotland

  • João Marcos Andrietta, Brazil

    João Marcos Andrietta, Brazil

  • Steven Spencer, New Zealand

    Steven Spencer, New Zealand

  • Mahmood Anwar, UK

    Mahmood Anwar, UK

  • Marcel R. Wernard, Netherlands

    Marcel R. Wernard, Netherlands

  • Ana María Zavala, Mexico

    Ana María Zavala, Mexico

  • Wilfried Leusing, Germany

    Wilfried Leusing, Germany

  • Ian Roberts, Australia

    Ian Roberts, Australia

  • Willi Klein, UK

    Willi Klein, UK

  • Chirag Walia, India

    Chirag Walia, India
    ChiragWalia

  • Richard Clark, New Zealand

    Richard Clark, New Zealand

  • PALS and CALS, Singapore

    PALS and CALS, Singapore

  • Oliver Juenke, Germany

    Oliver Juenke, Germany

  • Lachlan Terry, Australia

    Lachlan Terry, Australia

  • Kris Van Reusel, Belgium

    Kris Van Reusel, Belgium

  • Gudjon Sigurdsson, Iceland

    Gudjon Sigurdsson, Iceland

  • Shay Rishoni, Netherlands

    Shay Rishoni, Netherlands

  • Anderson Custodio Pinto, Brazil

    Anderson Custodio Pinto, Brazil

  • H. Todd Kelly, USA

    H. Todd Kelly, USA

  • Magdalena Ayala Rodríguez, Mexico

    Magdalena Ayala Rodríguez, Mexico

  • Natalya Rybakova, Russia

    Natalya Rybakova, Russia

  • Liam Dwyer, England

    Liam Dwyer, England

  • Angelique van der Lit-van Veldhuizen, Netherlands

    Angelique van der Lit-van Veldhuizen, Netherlands

  • Orlando Ruiz, Colombia

    Orlando Ruiz, Colombia

  • Ann Nicol, USA

    Ann Nicol, USA

  • Sally Pauls, USA

    Sally Pauls, USA

  • Margreth Burger-Saile, Switzerland

    Margreth Burger-Saile, Switzerland

  • Claudia Cominetti, Italy

    Claudia Cominetti, Italy

  • Michael Lee, Australia

    Michael Lee, Australia

  • Cath Muir, UK

    Cath Muir, UK
    Cath

  • Ailsa Malcolm-Hutton, UK

    Ailsa Malcolm-Hutton, UK

  • Susan Keldani, USA

    Susan Keldani, USA

  • Eddy Lefrancois, Canada

    Eddy Lefrancois, Canada

  • Art Eggert, USA

    Art Eggert, USA

  • Yannick Richard, Canada

    Yannick Richard, Canada
    yannickrichard

  • Mauril Belanger, Canada

    Mauril Belanger, Canada

  • Claudette Sturk, Canada

    Claudette Sturk, Canada
    Picture2

  • Mauril Bélanger, Canada

    Mauril Bélanger, Canada

  • Francisco Perez Palop, Spain

    Francisco Perez Palop, Spain

  • Steve Gallagher, Canada

    Steve Gallagher, Canada
    Picture1

  • Claudia Gotti, Brazil

    Claudia Gotti, Brazil

  • Maurice LeClerc, Canada

    Maurice LeClerc, Canada

Learn more about the March of Faces

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login